GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Recent study held under Dr. Ziyada Al-Aly found that GLP-1 medications can reduce the risk of disease like heart disease and ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and ...